Navigation Links
The Surgeons of Los Angeles Colon and Rectal Surgical Associates are Now Offering Exparel for Use in Local Anesthesia During Anorectal Operations
Date:5/14/2013

BEVERLY HILLS, CALIFORNIA (PRWEB) May 14, 2013

Los Angeles Colon and Rectal Surgical Associates is pleased to be able to offer the latest development in anesthesia and postoperative pain control to its patients in Los Angeles – Exparel®, a new type of drug delivery system for colorectal patients.

The use of an intra-operative local anesthetic, in the form of microsomal bupivicaine, will be of great benefit to large numbers of patients undergoing most forms of anorectal surgery. The operative site can be extremely uncomfortable after the procedures have been completed. The need for strong opioid pain medications is common, and these medications will often require that a regular dose be taken several times a day. The use of microsomal bupivicaine reduces this reliance on other pain medications, and makes the period of time immediately after surgery considerably more comfortable for the patient. Dr. Gary Hoffman, a senior physician at Los Angeles Colon and Rectal Surgeons, has stated, “Anorectal procedures in particular, can be quite painful during this recovery period, and microsomal bupivicaine promises to be an important adjunct in pain control and relief.”

Clinical Use During Anorectal Operations

“We have been very happy with our results to date,” said Dr. Gary Hoffman in Los Angeles. “Our results are bolstered by well-designed studies and trials supporting the use of this anesthetic delivery system. The system is effective and patient response has been positive. Our preliminary results echo the strong results seen in several institutions. Microsomal bupivicaine works because the delivery system is composed of microvesicles, or small bubbles if you will, which contain the anesthetic bupivicaine, which is delivered to the precise location where it is needed. It then diffuses slowly into the tissues, over 72 hours, and provides extended post-operative relief.”

About Exparel®, A New Type of Delivery System

Exparel® is a local anesthetic and delivery system injected into the affected area at the beginning of a medical operation. The anesthetic drug bupivicaine is used in conjunction with the delivery system known as DepoFoam®, and has been clinically proven to be safe and effective. The bupivicaine is surrounded by DepoFoam® in the form of microvesicles, and the use of Exparel® in this manner has been shown to reduce the need for opioid pain medications post-operatively. The anesthetic may be effective for up to 72 hours after injection.

The difference between microsomal bupvicaine and other types of local anesthetic injections is the manner in which it is delivered. While injections are used for the majority of local anesthestic drugs, the vesicles that contain the medication provide a slow release that leads to prolonged pain relief. Exparel® has been shown to be most effective when injected directly into the site of the operation, and often leads to an increase in the length of time before opioid pain relief is needed. Studies have shown the median time before opioids are used with normal local anesthesia is 1.2 hours. With Exparel®, this time increases to almost 15 hours, thus reducing the risks associated with opioid use. Additionally, administering Exparel® has reduced the amount of supplemental oral pain medication.

About Los Angeles Colon and Rectal Surgical Associates
Los Angeles Colon and Rectal Surgical Associates was formed in 1957, and provides patients with focused diagnostic, compassionate medical and surgical treatment. The doctors specialize in the diagnosis and treatment of various diseases that affect the colon, rectum, and anus, such as colon cancer, hemorrhoids, and colon polyps.

Los Angeles Colon and Rectal Surgical Associates hosts a website, http://www.LAcolon.com, which provides comprehensive information to help patients find helpful information. It has many pages that serve as a guide for people looking to learn more about the care offered by LACRSA. Additional information about the physicians is also found on the website. For convenience, there are downloadable forms available on the website for patients looking to schedule an appointment. LACRSA serves Los Angeles, Beverly Hills, Santa Monica, West Hollywood, Culver City, and all other parts of Southern California. The doctors also treat patients from many areas of the United States as well as international patients.

For more information or to see whether microsomal bupivicaine (Exparel®) would be suitable for you, contact Los Angeles Colon and Rectal Surgical Associates for an evaluation.

Los Angeles Colon and Rectal Surgical Associates
9400 Brighton Way, Suite 307
Beverly Hills, CA 90210
+1 (310) 273-2310

Read the full story at http://www.prweb.com/releases/2013/5/prweb10726011.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Clinical news alert from the American Academy of Orthopaedic Surgeons
2. NYU Langone experts present research, clinical advances at neurosurgeons meeting
3. Slicing mitotic spindle with lasers, nanosurgeons unravel old pole-to-pole theory
4. Clinical news alert: Journal of the American Academy of Orthopaedic Surgeons May highlights
5. Surgeons Seek Repeal of Transplant Ban Between HIV-Positive People
6. Greater availability of neurosurgeons could reduce risk of death from motor vehicle accidents
7. Adding More Neurosurgeons Could Cut Traffic Deaths: Study
8. General surgeons identify postoperative complications posing strongest readmission risk
9. Young Surgeons May Be Easily Distracted
10. In US first, Johns Hopkins surgeons implant brain pacemaker for Alzheimers disease
11. General thoracic surgeons emerge as leading providers of complex, noncardiac thoracic surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: